Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease
1Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, School of Medical Science, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Insights
Stem cell biology and cell reprogramming offer new hope for Huntington's disease (HD) research. These advances may lead to novel therapeutic strategies for this debilitating neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Regenerative Medicine
Background:
- Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion mutation in the huntingtin (HTT) gene.
- Despite the identification of the HTT gene two decades ago, therapeutic strategies for HD remain limited.
Purpose of the Study:
- To review the role of compensatory neurogenesis in the HD brain.
- To explore stem cell-based therapies for cell replacement and prevention of cell loss in HD.
- To discuss advancements in cell reprogramming for modeling and treating HD.
Main Methods:
- Review of recent literature on stem cell biology and cell reprogramming in the context of HD.
- Discussion of compensatory neurogenesis in the HD brain.
- Exploration of stem cell-based therapeutic approaches.
- Analysis of cell reprogramming techniques for HD modeling and treatment.
Main Results:
- Stem cell biology and cell reprogramming offer novel pathways to understand HD pathogenesis.
- These technologies facilitate the identification and screening of potential drug targets.
- Alternative donor cell sources for cell replacement therapy are being explored.
- Genome editing advances complement these new technologies.
Conclusions:
- Recent advances in stem cell biology and cell reprogramming present a promising new era for Huntington's disease research.
- These technologies hold potential for developing effective therapeutic strategies to alleviate HD.
- The integration of new technologies may lead to breakthroughs in treating this debilitating disorder.
Abstract:
Two decades ago, researchers identified that a CAG expansion mutation in the huntingtin (HTT) gene was involved in the pathogenesis of Huntington's disease (HD). However, since the identification of the HTT gene, there has been no advance in the development of therapeutic strategies to prevent or reduce the progression of HD. With the recent advances in stem cell biology and human cell reprogramming technologies, several novel and exciting pathways have emerged allowing researchers to enhance their understanding of the pathogenesis of HD, to identify and screen potential drug targets, and to explore alternative donor cell sources for cell replacement therapy. This review will discuss the role of compensatory neurogenesis in the HD brain, the use of stem cell-based therapies for HD to replace or prevent cell loss, and the recent advance of cell reprogramming to model and/or treat HD. These new technologies, coupled with advances in genome editing herald a promising new era for HD research with the potential to identify a therapeutic strategy to alleviate this debilitating disorder. Stem Cells 2018;36:146-160.
Related Concept Videos
EPS and iPS Cells in Disease Research
Stem Cell Culture
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...


